Anti-cancer agents in medicinal chemistryApr 25, 2025

New developments in binding metals to pyridine compounds may improve cancer-fighting strength (2022-2024)

Alzheimers & Treatments Weekly Brief ↗PubMed ↗DOI ↗

Updated Mar 31, 2026

Abstract

Pyridine-metal complexes may enhance anticancer properties through mechanisms such as ROS generation and DNA intercalation.

Pyridine and its derivatives may struggle with low bioavailability, poor solubility, and rapid metabolism.
Metal complexation is associated with improved stability and bioavailability of pyridine derivatives.
Pyridine-metal complexes exhibit potent cytotoxicity against cancer cells.
Mechanisms of action include the generation of reactive oxygen species (ROS), intercalation into DNA, and induction of apoptosis.
Preclinical studies demonstrate the efficacy of these complexes against various cancer types.

Simplified

Cancer remains a major global health challenge, necessitating innovative therapies that selectively target cancer cells while sparing healthy tissues. Pyridine and its derivatives have gained prominence in medicinal chemistry for their structural diversity and biological activity. However, their therapeutic potential is often hindered by low bioavailability, poor solubility, and rapid metabolism. Metal complexation has emerged as a promising solution, with pyridine nitrogen serving as an excellent coordination site for transition metals. These pyridinemetal complexes enhance stability, bioavailability, and anticancer properties, exhibiting potent cytotoxicity through mechanisms like ROS generation, DNA intercalation, and apoptosis induction. This review highlights the latest progress (2022-2024) in the field, emphasizing the structural modifications, and mechanistic insights that have propelled pyridine-metal complexes as potent anticancer agents. Special attention is given to the role of metal complexation in enhancing the anticancer potency of pyridine derivatives, with examples of preclinical studies showing their efficacy against various cancer types. The findings emphasize the potential of pyridine-metal complexes as a transformative approach in oncology, bridging the gap between innovative chemical design and impactful therapeutic applications.

Full Text

Full text is available at the source.

View Full Text ↗

New developments in binding metals to pyridine compounds may improve cancer-fighting strength (2022-2024)

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the alzheimers & treatments brief